Menu
My ERA ERA'ya Katıl

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Suggestions
My Era ERA'ya Katıl
Home | Yayınlar | Regulations

Regulations

ERA regulations.


10 / 78 sonuç bulundu

{%TITLE%}
{%SMALL_TITLE%}
{%TITLE%}
{%SUMMARY_INFO%}
{%TITLE%}

{%BOTTOM_TEXT%}

{%TITLE%}
{%SMALL_TITLE%}

{%EXCERPT%}

{%BOTTOM_TEXT%}

Daha fazla yükle